Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
Recently, agonistic autoantibodies (agAAb) activating the β2-adrenergic receptor were detected in primary open-angle glaucoma (POAG) or ocular hypertension (OHT) patients and were linked to intraocular pressure (IOP) (1). The aim of the present study was to quantify β2-agAAb in the sera of glaucoma...
Main Authors: | Bettina Hohberger, Rudolf Kunze, Gerd Wallukat, Katja Kara, Christian Y. Mardin, Robert Lämmer, Ursula Schlötzer-Schrehardt, Sami Hosari, Folkert Horn, Luis Munoz, Martin Herrmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02112/full |
Similar Items
-
Inhibitory and Agonistic Autoantibodies Directed Against the β2-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
by: Bettina Hohberger, et al.
Published: (2021-08-01) -
Agonistic β2-Adrenergic Receptor Autoantibodies Characterize the Aqueous Humor of Patients With Primary and Secondary Open-Angle Glaucoma
by: Bettina Hohberger, et al.
Published: (2021-05-01) -
Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
by: Anselm Jünemann, et al.
Published: (2018-02-01) -
Serum Biomarkers for the Diagnosis of Glaucoma
by: Young Joo Shin, et al.
Published: (2021-12-01) -
Medical treatment of open-angle glaucoma
by: Mohammed M Abdull, et al.
Published: (2012-01-01)